AU6624500A - G protein-coupled receptor expressed in brain - Google Patents

G protein-coupled receptor expressed in brain Download PDF

Info

Publication number
AU6624500A
AU6624500A AU66245/00A AU6624500A AU6624500A AU 6624500 A AU6624500 A AU 6624500A AU 66245/00 A AU66245/00 A AU 66245/00A AU 6624500 A AU6624500 A AU 6624500A AU 6624500 A AU6624500 A AU 6624500A
Authority
AU
Australia
Prior art keywords
con167
polypeptide
transmembrane receptor
receptor
transmembrane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU66245/00A
Other languages
English (en)
Inventor
Gabriel Vogeli
Linda S. Wood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Pharmacia and Upjohn Co
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co, Upjohn Co filed Critical Pharmacia and Upjohn Co
Publication of AU6624500A publication Critical patent/AU6624500A/en
Priority to AU2004210549A priority Critical patent/AU2004210549A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)
  • Anesthesiology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU66245/00A 1999-08-19 2000-08-08 G protein-coupled receptor expressed in brain Abandoned AU6624500A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2004210549A AU2004210549A1 (en) 1999-08-19 2004-09-09 G protein-coupled receptor expressed in brain

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37756399A 1999-08-19 1999-08-19
US09377563 1999-08-19
PCT/US2000/021566 WO2001014554A1 (fr) 1999-08-19 2000-08-08 Recepteur couple a la proteine g exprime dans le cerveau

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2004210549A Division AU2004210549A1 (en) 1999-08-19 2004-09-09 G protein-coupled receptor expressed in brain

Publications (1)

Publication Number Publication Date
AU6624500A true AU6624500A (en) 2001-03-19

Family

ID=23489628

Family Applications (1)

Application Number Title Priority Date Filing Date
AU66245/00A Abandoned AU6624500A (en) 1999-08-19 2000-08-08 G protein-coupled receptor expressed in brain

Country Status (5)

Country Link
EP (1) EP1204747A1 (fr)
JP (1) JP2003507068A (fr)
AU (1) AU6624500A (fr)
CA (1) CA2376406A1 (fr)
WO (1) WO2001014554A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002077200A2 (fr) * 2001-03-27 2002-10-03 Inscent, Inc Procedes efficaces destines a isoler des recepteurs fonctionnels couples a la proteine g et a identifier des effecteurs actifs, des procedes efficaces destines a isoler des proteines impliquees dans l'odorat et des procedes efficaces destines a isoler et a identifier des effecteurs actifs

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874243A (en) * 1997-03-28 1999-02-23 Smithkline Beecham Corporation OLRCC15 receptor

Also Published As

Publication number Publication date
EP1204747A1 (fr) 2002-05-15
WO2001014554A1 (fr) 2001-03-01
CA2376406A1 (fr) 2001-03-01
JP2003507068A (ja) 2003-02-25

Similar Documents

Publication Publication Date Title
US20050112660A1 (en) Novel G protein-coupled receptors
US20050255490A1 (en) Novel G protein-coupled receptors
AU1575601A (en) G protein-coupled receptors expressed in brain
EP0604603A1 (fr) Elements et procedes permettant la production de cadherines
EP1261710A2 (fr) Nouveaux recepteurs couples a la proteine g
US20050074808A1 (en) G protein-coupled receptor expressed in brain
US20020015998A1 (en) Novel G protein-coupled receptors
AU6624500A (en) G protein-coupled receptor expressed in brain
US20040091928A1 (en) G protein-coupled receptors expressed in brain
WO2001068858A2 (fr) Nouveaux recepteurs couples a la proteine g
EP1278844A2 (fr) Nouveaux recepteurs couples a la proteine g
AU2004210549A1 (en) G protein-coupled receptor expressed in brain
US20030170779A1 (en) Novel G protein-coupled receptors
JPH11511030A (ja) 新規なヒトｇ−蛋白質結合レセプター
US20050214790A1 (en) Novel G protein-coupled receptors
US20020137132A1 (en) Novel G protein-coupled receptors
US20050069976A1 (en) Protein-coupled receptor
WO2001062924A2 (fr) Nouveaux recepteurs couples a une proteine g
US20020052021A1 (en) Novel G protein-coupled receptors
US20030175857A1 (en) Novel G protein-coupled receptor
US20030032784A1 (en) Novel G protein-coupled receptors
US20030032019A1 (en) Novel G protein-coupled receptors
US20030023992A1 (en) Novel G protein-coupled receptors
US20020198368A1 (en) Novel G protein-coupled receptors
WO2001062798A2 (fr) Nouveaux recepteurs couples a la proteine g

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted